Predictive Factors for Return to Work After a First Stroke Treated at Clermont-Ferrand University Hospital in Puy de Dôme Between January 2020 and December 2024 (RTWS2)
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Lise Laclautre
- Phone Number: +33473754963
- Email: promo_interne_drci@chu-clermontferrand.fr
Study Locations
-
-
-
Clermont-Ferrand, France
- CHU Clermont-Ferrand, Louise Michel
-
-
France
-
Cébazat, France, France, 63118
- Clermont Ferrand University Hospital, Louise Michel site
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who have suffered an ischaemic stroke according to ICD-10 (ICD-10 code: I63 (cerebral infarction) I64 (unspecified stroke), I69 (sequelae of cerebrovascular disease) or patients who have had a haemorrhagic stroke according to ICD-10 (ICD-10 code: I60, I61 and I62) between January 2020 and March 2024
- Patients of working age/under 64 years of age (legal retirement age)
- Patients with an employment contract at the time of the stroke
- Patients treated at Clermont-Ferrand University Hospital
- Post-stroke consultation recorded in the patient's medical file
- Patients affiliated with the social security system
- Patients who have not objected to participating in the study
Exclusion Criteria:
- Patients with a history of ischaemic or haemorrhagic stroke
- Patients with a history of head trauma with neurological sequelae corresponding to codes S060, S061, S062, S063, S065, S066, S067, S068 and S069
- Patients who died as a result of stroke
- Patients unable to respond to telephone questionnaires
- Patients under guardianship or trusteeship
- Patients who have suffered a transient ischaemic attack (TIA) (G459 according to ICD 10)
- Patients who were in early retirement at the time of assessment
- No information on employment after stroke in the medical file
- Patients with category 2 or 3 disability prior to stroke due to another condition
- Patients on sick leave prior to stroke due to another condition
- Patients receiving RSA income support
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return to work rate
Time Frame: At inclusion
|
Percentage of return to work after a first ischaemic or haemorrhagic stroke between January 2020 and December 2024 in patients of working age.
|
At inclusion
|
|
Factors correlated with return to work
Time Frame: At inclusion
|
Determine the factors associated with return to work (gender)
|
At inclusion
|
|
Factors correlated with return to work
Time Frame: At inclusion
|
Determine the factors associated with return to work (stroke severity)
|
At inclusion
|
|
Factors correlated with return to work
Time Frame: At inclusion
|
Determine the factors associated with return to work (stroke type (ischaemic or haemorrhagic)).
|
At inclusion
|
|
Factors correlated with return to work
Time Frame: At inclusion
|
Determine the factors associated with return to work (independence)
|
At inclusion
|
|
Factors correlated with return to work
Time Frame: At inclusion
|
Determine the factors associated with return to work (occupation)
|
At inclusion
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life after stroke
Time Frame: At inclusion
|
The Short-Form-12 (SF-12) questionnaire is a standardized self-administered questionnaire used to assess health-related quality of life.
It comprises 12 questions covering 8 domains: physical activities, physical and mental limitations, pain, perceived general health, vitality, mental health and social relationships.
Each item is rated on a 5- or 6-point Likert scale.
The responses are used to calculate two scores: a physical composite score (PCS) and a mental composite score (MCS), each ranging from 0 (perceived health status very poor) to 100 (perceived health status optimal).
|
At inclusion
|
|
Anxiety and Depression scale
Time Frame: At inclusion
|
The Hospital Anxiety and Depression Scale (HADs) questionnaire is a psychometric self-assessment questionnaire consisting of 14 items divided into two subscales (anxiety and depression) of seven items each.
Each item is rated on a scale of 0 to 3. A score is given for each subscale, A for anxiety and D for depression.
The score can range from 0 (no anxiety and/or depressive disorders) to 21 (proven anxiety and/or depressive disorders of varying severity) for each subscale.
|
At inclusion
|
|
Fatigue Severity Scale
Time Frame: At inclusion
|
The Fatigue Severity Scale (FSS) questionnaire is a self-assessment tool used to evaluate the severity of fatigue and its impact on daily activities.
This questionnaire consists of nine items rated on a seven-point Likert scale, ranging from 1 ('strongly disagree') to 7 ('strongly agree').
The score ranges from 7 (no fatigue in daily activities) to 63 (extreme fatigue in daily activities).
A score above 36 indicates that the patient may need to have their fatigue assessed by a healthcare professional.
|
At inclusion
|
|
Predictive score for return-to-work rate
Time Frame: At inclusion
|
Develop a predictive score for return to work using the predictive factors for return to work identified in the main objective.
|
At inclusion
|
|
Job retention
Time Frame: At inclusion
|
To study job retention and its association with factors such as stroke severity.
|
At inclusion
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Lise Laclautre, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RNI 2025 ORANGE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.